| TGTX Stock Yearly Return 2024 Table | ||||||||||||||||||||||||||||||
TGTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare TGTX average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| TGTX Share Performance |
| TGTX Stock Yearly Return 2024 Chart | |||
Also see: • TGTX YTD return • TGTX average annual return 10 years | |||
| About TG Therapeutics Inc |
| TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. Co. is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. The TGTX stock yearly return is shown above.
The yearly return on the TGTX stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2024 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the TGTX annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| TGTX Current Stock Quote |
 Free TGTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| TG Therapeutics (TGTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
THAR Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.
Video: Don't Forget Dividends in Average Annual Return!